WallStreetZenWallStreetZen

NYSE: CHE
Chemed Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Chemed earnings were $265.2M for the trailing 12 months ending Dec 31, 2025, with -8.4% growth year over year. The latest CHE earnings report on Dec 31, 2025 announced Q4 2025 earnings of $76.8M, up 19.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CHE reported annual earnings of $265.2M, with -12.2% growth. The next CHE earnings date is Apr 29, 2026.

CHE past earnings growth

How has CHE's earnings growth performed historically?

Company
-8.36%
Industry
23.1%
Market
87.43%
CHE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CHE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CHE's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CHE earnings history

Current Revenue
$2.5B
Current Earnings
$265.2M
Current Profit Margin
10.5%
CHE's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CHE Return on Equity

Current Company
23.9%
Current Industry
-62%
Current Market
28.8%
CHE's Return on Equity (23.9%)... subscribe to Premium to read more.
High Return on Equity Performance

CHE Return on Assets

Current Company
16.1%
Current Industry
7.8%
CHE is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CHE announces earnings.

CHE Return on Capital Employed

Current Company
28.58%
Current Industry
19.2%
CHE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CHE vs Medical Care Facility Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CHE$422.37M$265.24M-1.65%$18.42
PACS$417.01M$191.54M+35.03%$1.23
OPCH$433.16M$207.59M+13.18%$1.28
BKD$344.00M-$262.69MN/A-$1.12
CON$402.50M$166.42M-10.10%$1.30
View Top Medical Care Facility Stocks

CHE earnings dates

Next earnings date
Apr 29, 2026

Chemed Earnings Reports & History FAQ

What were Chemed's earnings last quarter?

On CHE's earnings call on Invalid Date, Chemed (NYSE: CHE) reported Q4 2025 earnings per share (EPS) of $5.45, up 10.07% year over year. Total CHE earnings for the quarter were $76.75 million. In the same quarter last year, Chemed's earnings per share (EPS) was $6.06.

If you're new to stock investing, here's how to buy Chemed stock.

When does Chemed report earnings?

The next CHE earnings call is Invalid Date. Add CHE to your watchlist to be reminded of Chemed's next earnings date.

Is Chemed profitable or losing money?

As of the last Chemed earnings report, Chemed is currently profitable. Chemed's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $265.24 million, a 12.17% decrease year over year.

What was CHE's earnings growth in the past year?

As of Chemed's earnings date in Invalid Date, Chemed's earnings has grown -8.36% year over year. This is 31.46 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 23.1%. CHE earnings in the past year totalled $265.24 million.

What are Chemed's earnings expectations?

The current EPS estimate for Chemed's earnings report in Invalid Date is $5.99.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.